Cargando…
B-cell depletion with rituximab: a promising treatment for diffuse cutaneous systemic sclerosis
Recent preclinical and clinical studies lend support to the notion that B-cell depletion is a promising therapeutic target in patients with diffuse cutaneous systemic sclerosis. A recent open-label trial provides further evidence showing marked effects of rituximab treatment on skin thickening, func...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888215/ https://www.ncbi.nlm.nih.gov/pubmed/20441607 http://dx.doi.org/10.1186/ar2977 |